Main study measure wording changed
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: Posology: Proportion of participants free from Pericarditis Recurrence by Week 16 Time frame: From first administration of study drug up to Week 16 Measure: Long-Term Extension: Annualized rate of Pericarditis Recurrence through the end of the LTE. Time frame: Up to 24 Months. After: Measure: Posology: Proportion of participants free from Pericarditis Recurrence by Week 16 Time frame: From baseline up to Week 16 Measure: Long-Term Extension: Annualized rate of Pericarditis Recurrence through the end of the LTE. Time frame: Up to 24 Months.
Planned enrollment increased by 40 participants
Before: 80 participants (planned). After: 120 participants (planned).